Tersera Therapeutics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 168

Employees

  • Latest Deal Type
  • Debt Refin.

  • Financing Rounds
  • 12

  • Investments
  • 7

Tersera Therapeutics General Information

Description

Manufacturer of specialty pharmaceutical products intended to provide improved outcomes for patients. The company specializes in acquiring, developing and marketing specialty pharmaceutical products with a focus on select therapeutic areas.

Contact Information

Website
www.tersera.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 520 Lake Cook Road
  • Suite 500
  • Deerfield, IL 60015
  • United States
+1 (888)
Primary Industry
Pharmaceuticals
Other Industries
Holding Companies
Other Healthcare Services
Vertical(s)
Manufacturing
Corporate Office
  • 520 Lake Cook Road
  • Suite 500
  • Deerfield, IL 60015
  • United States
+1 (888)

Tersera Therapeutics Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tersera Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Tersera Therapeutics‘s full profile, request access.

Request a free trial

Tersera Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of specialty pharmaceutical products intended to provide improved outcomes for patients. The company specia
Pharmaceuticals
Deerfield, IL
168 As of 2023

Orth An Der Donau, Austria
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tersera Therapeutics Competitors (1)

One of Tersera Therapeutics’s competitors is Pfizer Manufacturing Austria, a Corporation company based in Orth An Der Donau, Austria.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pfizer Manufacturing Austria Corporation Orth An Der Donau, Austria
You’re viewing 1 of 1 competitors. Get the full list »

Tersera Therapeutics Patents

  • 139

    Total Documents Applications and Grants

  • Total Patents Families

  • 103

    Granted

  • 6

    Pending

  • Expiring in next 12 mo

Tersera Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230310434-A1 Methods of reducing the likelihood of carcinoid heart disease in patients with neuroendocrine tumors Pending 01-Apr-2022
US-11459399-B2 Pharmaceutical compositions of a her2/neu antibody and use of the same Active 04-Dec-2020
US-20220177602-A1 Pharmaceutical compositions of a her2/neu antibody and use of the same Active 04-Dec-2020
US-20230053747-A1 Pharmaceutical compositions of a her2/neu antibody and use of the same Pending 04-Dec-2020
US-20210353624-A1 Method of treating cancer with telotrisat or a prodrug thereof Inactive 13-May-2020 A61K31/506
To view Tersera Therapeutics’s complete patent history, request access »

Tersera Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tersera Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Tersera Therapeutics‘s full profile, request access.

Request a free trial

Tersera Therapeutics Investments (7)

Tersera Therapeutics’s most recent deal was a Buyout/LBO with Margenza for . The deal was made on 12-Nov-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Margenza 12-Nov-2024 Buyout/LBO Buildings and Property
Xermelo 08-Sep-2020 Buyout/LBO Pharmaceuticals
Prialt 27-Sep-2018 Buyout/LBO Drug Discovery
Tesaro (North American rights of VARUBI) 12-Jul-2018 Buyout/LBO Buildings and Property
AstraZeneca (Zoladex commercial rights) 31-Mar-2017 Buyout/LBO Buildings and Property
You’re viewing 5 of 7 investments. Get the full list »

Tersera Therapeutics Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Xermelo TX
Prialt

Tersera Therapeutics FAQs

  • When was Tersera Therapeutics founded?

    Tersera Therapeutics was founded in 2016.

  • Where is Tersera Therapeutics headquartered?

    Tersera Therapeutics is headquartered in Deerfield, IL.

  • What is the size of Tersera Therapeutics?

    Tersera Therapeutics has 168 total employees.

  • What industry is Tersera Therapeutics in?

    Tersera Therapeutics’s primary industry is Pharmaceuticals.

  • Is Tersera Therapeutics a private or public company?

    Tersera Therapeutics is a Private company.

  • What is Tersera Therapeutics’s current revenue?

    The current revenue for Tersera Therapeutics is .

  • How much funding has Tersera Therapeutics raised over time?

    Tersera Therapeutics has raised $297M.

  • Who are Tersera Therapeutics’s investors?

    Brookfield Oaktree Holdings and GTCR have invested in Tersera Therapeutics.

  • Who are Tersera Therapeutics’s competitors?

    Pfizer Manufacturing Austria is a competitor of Tersera Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »